Siegfried Wurster
Hoofd Techniek/Wetenschap/O&O bij Karyon-CTT Oy
Profiel
Siegfried Wurster is Chief Scientific Officer of Karyon-CTT Oy.
Prior to joining Karyon in 2006 he was Director of Sciences at Juvantia Pharma Ltd.
Dr. Wurster holds a PhD in Chemistry from the University of Freiburg.
Actieve functies van Siegfried Wurster
| Bedrijven | Functie | Begin |
|---|---|---|
Karyon-CTT Oy
 Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland. | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 |
Eerdere bekende functies van Siegfried Wurster
| Bedrijven | Functie | Einde |
|---|---|---|
Juvantia Pharma Oy
 Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Siegfried Wurster
| University of Freiburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Juvantia Pharma Oy
Juvantia Pharma Oy Miscellaneous Commercial ServicesCommercial Services Juvantia Pharma Oy discovers and develops pharmaceuticals and drugs. The firm develops products for the treatment of Parkinson's disease, depression and schizophrenia, vasoconstrictive disorders, fibro proliferative vasculopathies and chronic pain.The company was founded by Risto Arvo Sakari Lammintausta in 1997 and is headquartered in Turku, Finland. | Commercial Services |
Karyon-CTT Oy
Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland. | Commercial Services |
